mazindol has been researched along with Growth Disorders in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nine children with Duchenne muscular dystrophy were given Sanorex (mazindol), a growth hormone inhibitor, daily for 6 months." | 7.67 | Growth hormone inhibition causes increased selenium levels in Duchenne muscular dystrophy: a possible new approach to therapy. ( Angulo, M; Castro-Magana, M; Chen, SY; Collipp, PJ; Derenoncourt, A; Kelemen, J, 1984) |
| "Nine children with Duchenne muscular dystrophy were given Sanorex (mazindol), a growth hormone inhibitor, daily for 6 months." | 3.67 | Growth hormone inhibition causes increased selenium levels in Duchenne muscular dystrophy: a possible new approach to therapy. ( Angulo, M; Castro-Magana, M; Chen, SY; Collipp, PJ; Derenoncourt, A; Kelemen, J, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collipp, PJ | 1 |
| Kelemen, J | 1 |
| Chen, SY | 1 |
| Castro-Magana, M | 1 |
| Angulo, M | 1 |
| Derenoncourt, A | 1 |
1 other study available for mazindol and Growth Disorders
| Article | Year |
|---|---|
Growth hormone inhibition causes increased selenium levels in Duchenne muscular dystrophy: a possible new approach to therapy.
Topics: Adolescent; Body Height; Body Weight; Child; Child, Preschool; Growth Disorders; Growth Hormone; Hai | 1984 |